Aging and cancer cell biology, 2007

Aging Cell

Volumn 6, Issue 3, 2007, Pages 261-263

  Campisi, Judith ^a,b  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

Apoptosis; Metalloproteinase; p16 INK4a; p53; Senescence; Stem cell

Indexed keywords

ARF PROTEIN; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; PROTEIN MDM2; PROTEIN P16INK4A; PROTEIN P53;

AGING; ANGIOGENESIS; CANCER; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER MORTALITY; CANCER RISK; CELL AGING; CELL FUNCTION; CELL PROLIFERATION; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

AGED; AGING; ANIMALS; APOPTOSIS; CELL AGING; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HUMANS; MICE; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MDM2; STEM CELLS; TUMOR SUPPRESSOR PROTEIN P53;

MUS;

EID: 34249071088     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2007.00292.x     Document Type: Review

References (12)

1. Bilousova G, Marusyk A, Porter CC, Cardiff RD, DeGregori J (2005) Impaired DNA replication within progenitor cell pools promotes leukemogenesis. PLoS Biol. 3, e401.
2. Garcia-Cao I, Garcia-Cao M, Martin-Caballero J, Criado LM, Klatt P, Flores JM, Weill JC, Blasco MA, Serrano M (2002) 'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J. 21, 6225-6235.
3. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100, 57-70.
4. Janzen V, Forkert R, Fleming H, Saito Y, Waring MT, Dombkowski DM, Cheng T, DePinho RA, Sharpless NE, Scadden DT (2006) Stem cell aging modified by the cyclin-dependent kinase inhibitor, p16 INK4a. Nature 443, 421-426.
5. Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S, Sharpless NE (2006) p16 INK4a induces an age-dependent decline in islet regenerative potential. Nature 443, 453-457.
6. Maier B, Gluba W, Bernier B, Turner T, Mohammad K, Guise T, Sutherland A, Thorner M, Scrable H (2004) Modulation of mammalian life span by the short isoform of p53. Genes Dev. 18, 306-319.
7. Matheu A, Pantoja C, Efeyan A, Criado LM, Martin-Caballero J, Flores JM, Klatt P, Serrano M (2004) Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging. Genes Dev. 18, 2736-2746.
8. Mendrysa SM, O'leary KA, McElwee MK, Michalowski J, Eisenman RN, Powell DA, Perry ME (2006) Tumor suppression and normal aging in mice with constitutively high p53 activity. Genes Dev 20, 16-21.
9. Molofsky AV, Slutsky SG, Joseph NM, He S, Pardal R, Krishnamurthy J, Sharpless NE, Morrison SJ (2006) Declines in forebrain progenitor function and neurogenesis during aging are partially caused by increasing Ink4a expression. Nature 443, 448-452.
10. Reed MJ, Edelberg JM (2004) Impaired angiogenesis in the aged. Sci Aging Knowl. Environ. 2004, pe7.
11. Reed MJ, Karres N, Eyman D, Cruz A, Brekken RA, Plymate S (2007) The effects of aging on tumor growth and angiogenesis are tumor-cell dependent. Int. J. Cancer 120, 753-760.
12. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Ingelmann H, Lu X, Soron G, Cooper B, Brayton C, Park SH, Thompson T, Karsenty G, Bradley A, Donehower LA (2002) p53 mutant mice that display early aging-associated phenotypes. Nature 415, 45-53.